Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Potential new tariffs for all medical devices | Mavacamten & nonobstructive HCM | AI delivers—but not every time

News You Need to Know Today
Potential new tariffs for all medical devices | Mavacamten & nonobstructive HCM | AI delivers—but not every time
Monday, September 29, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

U.S. considering new tariffs for heart valves, imaging equipment and other medical devices

The Department of Commerce is seeking more information about how current trade policies are impacting the U.S. medtech industry. The investigation could lead to the creation of new tariffs. Public comments are being accepted until Oct. 17, and the findings will be presented to President Donald Trump.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

U.S. considering new tariffs for heart valves, imaging equipment and other medical devices

Share on Twitter Share on Facebook Share on Linkedin
The Department of Commerce is seeking more information about how current trade policies are impacting the U.S. medtech industry. The investigation could lead to the creation of new tariffs. Public comments are being accepted until Oct. 17, and the findings will be presented to President Donald Trump.
READ MORE >

Mavacamten fails to boost outcomes for patients with nonobstructive HCM

The drug, already approved by the FDA to treat obstructive HCM, failed to outperform a placebo after 48 weeks.

READ MORE >
pharmaceutical drug approval process
Share on Twitter Share on Facebook Share on Linkedin

Mavacamten fails to boost outcomes for patients with nonobstructive HCM

Share on Twitter Share on Facebook Share on Linkedin
pharmaceutical drug approval process
The drug, already approved by the FDA to treat obstructive HCM, failed to outperform a placebo after 48 weeks.
READ MORE >

AI delivers helpful heart health advice—but not every time

AI-powered chatbots can be valuable resources when users have questions about cardiovascular health—but they are still far from perfect.

READ MORE >
robot reviewing heart data
Share on Twitter Share on Facebook Share on Linkedin

AI delivers helpful heart health advice—but not every time

Share on Twitter Share on Facebook Share on Linkedin
robot reviewing heart data
AI-powered chatbots can be valuable resources when users have questions about cardiovascular health—but they are still far from perfect.
READ MORE >

Featured Articles

How to bring cardiologists to rural America during a physician shortage

As the national physician shortage deepens, cardiology is feeling the strain. Recruiting cardiologists can be hard enough—bringing them to rural America is especially challenging due to the risk of isolation and other concerns.

READ MORE >
As the national physician shortage deepens, cardiology is feeling the strain—especially in rural America. Recruitment challenges are growing, and health systems are grappling with how to attract and retain cardiologists in remote locations. Michelle Wimberly, director of physician recruitment and retention at Cardiovascular Logistics (CVL), says the solution starts with relationships and a commitment to long-term engagement.
Share on Twitter Share on Facebook Share on Linkedin

How to bring cardiologists to rural America during a physician shortage

Share on Twitter Share on Facebook Share on Linkedin
As the national physician shortage deepens, cardiology is feeling the strain—especially in rural America. Recruitment challenges are growing, and health systems are grappling with how to attract and retain cardiologists in remote locations. Michelle Wimberly, director of physician recruitment and retention at Cardiovascular Logistics (CVL), says the solution starts with relationships and a commitment to long-term engagement.
As the national physician shortage deepens, cardiology is feeling the strain. Recruiting cardiologists can be hard enough—bringing them to rural America is especially challenging due to the risk of isolation and other concerns.
READ MORE >

A call to action for pediatric cardiologists: CVD prevention begins at childhood

Pediatric cardiologists can make a significant impact on global health trends by looking for early warning signs of CVD in their patients and collaborating with other physicians.

READ MORE >
childrens-health-doctors_thumb.jpg
Share on Twitter Share on Facebook Share on Linkedin

A call to action for pediatric cardiologists: CVD prevention begins at childhood

Share on Twitter Share on Facebook Share on Linkedin
childrens-health-doctors_thumb.jpg
Pediatric cardiologists can make a significant impact on global health trends by looking for early warning signs of CVD in their patients and collaborating with other physicians.
READ MORE >

CVD responsible for 1 in 3 deaths around the world

Cardiovascular disease remains the world’s leading cause of death, according to a special report from the American College of Cardiology. The new analysis, described by one cardiologist as a "wake-up call," includes data from more than 200 countries and territories.

READ MORE >
Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.
Share on Twitter Share on Facebook Share on Linkedin

CVD responsible for 1 in 3 deaths around the world

Share on Twitter Share on Facebook Share on Linkedin
Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.
Cardiovascular disease remains the world’s leading cause of death, according to a special report from the American College of Cardiology. The new analysis, described by one cardiologist as a "wake-up call," includes data from more than 200 countries and territories.
READ MORE >

How TAVR device type may impact outcomes in patients with excessive cusp calcification

Should patients with excessive cusp calcification be treated with self-expanding or balloon-expandable TAVR devices? Each valve type appears to be associated with its own benefits and risks.

READ MORE >
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Share on Twitter Share on Facebook Share on Linkedin

How TAVR device type may impact outcomes in patients with excessive cusp calcification

Share on Twitter Share on Facebook Share on Linkedin
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Should patients with excessive cusp calcification be treated with self-expanding or balloon-expandable TAVR devices? Each valve type appears to be associated with its own benefits and risks.
READ MORE >

In Case You Missed It

Update: FDA confirms recalls for defibrillation leads after nearly 400 injuries

Safety concerns with certain Boston Scientific leads have resulted in multiple Class I recalls, the FDA has announced. The agency first shared a warning about this issue in August. 

READ MORE >
Recall | Product recall
Share on Twitter Share on Facebook Share on Linkedin

Update: FDA confirms recalls for defibrillation leads after nearly 400 injuries

Share on Twitter Share on Facebook Share on Linkedin
Recall | Product recall
Safety concerns with certain Boston Scientific leads have resulted in multiple Class I recalls, the FDA has announced. The agency first shared a warning about this issue in August. 
READ MORE >

Cardiologist sues hospital after he was allegedly let go for sharing safety concerns

The veteran interventional cardiologist claims he was pushed out after repeatedly asking for more coverage from cardiothoracic surgeons in addition to other improvements. The hospital, meanwhile, described the lawsuit as a “collection of false allegations."

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist sues hospital after he was allegedly let go for sharing safety concerns

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
The veteran interventional cardiologist claims he was pushed out after repeatedly asking for more coverage from cardiothoracic surgeons in addition to other improvements. The hospital, meanwhile, described the lawsuit as a “collection of false allegations."
READ MORE >

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately

The FDA has categorized this as a Class I recall. If patients update their phone or watch apps as needed, they can continue to use these devices like normal.

READ MORE >
The Dexcom G7 Continuous Glucose Monitoring System
Share on Twitter Share on Facebook Share on Linkedin

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately

Share on Twitter Share on Facebook Share on Linkedin
The Dexcom G7 Continuous Glucose Monitoring System
The FDA has categorized this as a Class I recall. If patients update their phone or watch apps as needed, they can continue to use these devices like normal.
READ MORE >

In Other News

Healthcare AI today: Blind prior-auth pilots, sputtering healthtech romance, solo AI surgeons, more

Meet a robot surgeon who could operate on patients with no human in the room. 

READ MORE >
robot surgeon solo AI
Share on Twitter Share on Facebook Share on Linkedin

Healthcare AI today: Blind prior-auth pilots, sputtering healthtech romance, solo AI surgeons, more

Share on Twitter Share on Facebook Share on Linkedin
robot surgeon solo AI
Meet a robot surgeon who could operate on patients with no human in the room. 
READ MORE >

New GE HealthCare partnership expands access to prostate cancer imaging agent

The product, which is used to detect metastatic or recurrent prostate cancer, was approved by the FDA in 2021. 

READ MORE >
Prostate Blue Ribbon
Share on Twitter Share on Facebook Share on Linkedin

New GE HealthCare partnership expands access to prostate cancer imaging agent

Share on Twitter Share on Facebook Share on Linkedin
Prostate Blue Ribbon
The product, which is used to detect metastatic or recurrent prostate cancer, was approved by the FDA in 2021. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

FDA warns public after patient death | Medtronic recalls heart devices | 'Compelling' new PE data | Pushing for TAVR changes
News Alert: Medtronic recalls thousands of surgical devices
New IVL tech overcomes previous limitations | 3-year SMART data looks at TAVR outcomes | Artivion acquires Endospan for $135M
FDA approves next-gen mitral valve | Doctors are first in world to use new TAVR technique | Preventing a common complication
Key updates in PFA & beyond | More good IVL news for Boston Scientific | FDA approves new hypertension drug
Cardiologists scramble to prepare for new policy | Boston Scientific invests $1.5B in TAVR developer | FDA clears cath lab tech
The latest on PFA risks | EP catheters recalled | Doctors exempt from work visa freeze | Good news for Heartflow

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Page 2
    • Page 3
    • Current page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup